Stryker Corporation (SYK)
Return on total capital
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 4,499,000 | 3,888,000 | 4,029,000 | 3,020,000 | 2,618,000 |
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 22,420,000 | 20,634,000 | 18,593,000 | 16,616,000 | 14,877,000 |
| Return on total capital | 20.07% | 18.84% | 21.67% | 18.18% | 17.60% |
December 31, 2025 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $4,499,000K ÷ ($—K + $22,420,000K)
= 20.07%
Peer comparison
Dec 31, 2025
Company name
Symbol
Return on total capital
Stryker Corporation
SYK
20.07%
Abbott Laboratories
ABT
15.98%
CONMED Corporation
CNMD
20.81%